, ACS Chem. Biol, vol.9, pp.353-358, 2014.
Preparation of 2-anilino-4-heteroarylpyrimidine compounds for inhibition of mutant EGFR and mutant HER2 kinase, PCT Int. Appl. WO2015175632A1, 2015. ,
Preparation of (substituted phenyl) (substituted pyrimidine) amino deriv. as anticancer drugs, PCT Int. Appl. WO2016029839A1, 2016. ,
Deuterated 3-(4,5-substituted pyrimidinamine) phenyl derivative useful in treatment of cancer and its preparation, PCT Int. Appl ,
, WO2018050108A1, 2018.
, Eur. J. Med. Chem, vol.135, pp.12-23, 2017.
, , vol.4, pp.53837-53841, 2014.
, , vol.22, pp.16042-16046, 2016.
, Org. Lett, vol.4, pp.2853-2856, 2002.
, Tetrahedron Lett, vol.50, pp.4878-4881, 2009.
, Org. Lett, vol.15, pp.5294-5297, 2013.
, Org. Lett, vol.18, pp.1178-1181, 2016.
, J. Org. Chem, vol.82, pp.745-753, 2017.
, , vol.83, pp.14733-14742, 2018.
, Heterocycles, vol.23, pp.2327-2333, 1985.
, Heterocycles, vol.31, pp.1951-1958, 1990.
, Chem. Lett, vol.36, pp.200-205, 2007.
, Tetrahedron, vol.65, pp.10269-10310, 2009.
, Angew. Chem., Int. Ed, vol.48, pp.9792-9826, 2009.
, Adv. Synth. Catal, vol.356, pp.17-117, 2014.
, Angew. Chem., Int. Ed, vol.57, pp.2296-2306, 2018.
, , vol.11, pp.269-286, 2019.
, J. Org. Chem, vol.72, pp.1476-1479, 2007.
, Tetrahedron, vol.63, 1970.
, Angew. Chem., Int. Ed, vol.47, pp.1473-1476, 2008.
, J. Org. Chem, vol.73, pp.7428-7431, 2008.
, Adv. Synth. Catal, vol.352, pp.2929-2936, 2010.
, Org. Lett, vol.12, pp.3185-3187, 2010.
, , vol.16, pp.5876-5881, 2010.
, Chem. Commun, vol.47, pp.806-808, 2011.
, , vol.23, pp.2992-2996, 2012.
,
, Adv. Synth. Catal, vol.354, pp.335-340, 2012.
, Chem. Pharm. Bull, vol.37, pp.1477-1480, 1989.
, Tetrahedron Lett, vol.48, pp.2415-2419, 2007.
, Tetrahedron Lett, vol.49, pp.2499-2502, 2008.
, J. Org. Chem, vol.73, pp.5529-5535, 2008.
, , pp.808-812, 2009.
, Org. Lett, vol.11, pp.5506-5509, 2009.
, , vol.5, pp.255-262, 2013.
, Organomet. Chem, vol.687, pp.365-376, 2003.
, J. Am. Chem. Soc, vol.132, pp.14676-14681, 2010.
, License and Terms